%0 Journal Article %1 srensen2020biovacc19 %A Sørensen, B. %A Susrud, A. %A Dalgleish, A. G. %D 2020 %J Sørensen, B., Susrud, A., & Dalgleish, A. G. (2020). Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity. QRB Discovery, 1, e6. https://doi.org/10.1017/qrd.2020.8 %K covid-19 vaccine %T Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity.

@article{srensen2020biovacc19, added-at = {2020-12-26T19:30:27.000+0100}, author = {Sørensen, B. and Susrud, A. and Dalgleish, A. G.}, biburl = {https://www.bibsonomy.org/bibtex/2da8bd98a96ace2f1c106bb17773b5980/fordham1}, description = {Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity}, interhash = {8aeb60158bada4497bea97565f60ff47}, intrahash = {da8bd98a96ace2f1c106bb17773b5980}, journal = {Sørensen, B., Susrud, A., & Dalgleish, A. G. (2020). Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity. QRB Discovery, 1, e6. https://doi.org/10.1017/qrd.2020.8}, keywords = {covid-19 vaccine}, timestamp = {2020-12-26T19:30:27.000+0100}, title = {Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity. }, year = 2020 }